OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
RGBP
Regen Biopharma, Inc.
Common Stock
0.043
-0.0001
-0.23%
0.043 / 0.0599 (1 x 1)
Real-Time Best Bid & Ask: 05:00pm 07/14/2025
Delayed (15 Min) Trade Data: 12:00am 07/14/2025
0.0432
0.043 - 0.04821
302,214
N/A
Real-Time Level 2 Quote
Bid
Ask
MPID MPID | Bid Price Bid Price | Size Size | Time Time |
|---|---|---|---|
ETRF | 24.90 | >year | |
CDEL | 21.92 | 03/16 | |
MACM | 18.95 | >year | |
NITE | 18.95 | >year | |
CSTI | 18.55 | >year |
MPID MPID | Ask Price Ask Price | Size Size | Time Time |
|---|---|---|---|
INTL | 19.40 | >year | |
NITE | 19.40 | >year | |
MACM | 19.43 | >year | |
MAXM | 20.11 | >year | |
CANT | 22.05 | >year |
Unlock Real-Time quotes For RGBPFind Out More
Trade Data
Date Date | Timestamp Timestamp | Price Price | $ Change $ Change | Volume Volume |
|---|---|---|---|---|
| 07/14/2025 | 14:51:19 | 0.043 | -0.00 | 278,014 |
| 07/14/2025 | 14:51:19 | 0.0431 | -0.00 | 10,000 |
| 07/14/2025 | 14:51:09 | 0.0432 | 0.00 | 1,786 |
| 07/14/2025 | 14:51:09 | 0.0432 | -0.00 | 10,000 |
| 07/14/2025 | 14:51:09 | 0.0456 | 0.00 | 200 |
News
Presenting on Emerging Growth Conference 81 Day 2 on April 17; Register to live streamGlobeNewswire | 04/16/2025
Presenting on the Emerging Growth Conference 80 Day 2 on March 27 Register NowGlobeNewswire | 03/26/2025
Presenting on the Emerging Growth Conference 79 Day 1 on February 18 Register NowGlobeNewswire | 02/18/2025
Filings and Disclosure
Company Description
Regen BioPharma Inc. is a publicly traded biotechnology company (OTCQB: RGBP) and (OTCQB: RGBPP). The Company is focused on the immunology and immunotherapy space. The Company is focused on rapidly advancing novel technologies through pre-clinical and Phase I/ II clinical trials. Currently, the Company is focused on small molecule therapies for treating cancer and autoimmune disorders. Additional information on Regen BioPharma is available at http://www.regenbiopharmainc.com.
Videos
This company has not added any videos
OTCID
The Company Profile data was verified by the issuer within the previous 6 months.
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
Securities
Other Regen Biopharma, Inc. Securities
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.
Loading...
Symbol
OTCM
Last
57.3755
Change
-0.0345 (-0.06%)
Bid
56.30
Ask
57.50
Volume
2595
Time
00:00
